Literature DB >> 12526030

Apolipoprotein E expression after spinal cord injury in the mouse.

Alexander Seitz1, Maja Kragol, Elsa Aglow, Louise Showe, Ellen Heber-Katz.   

Abstract

Apolipoprotein E (apo-E), a protein involved in lipid metabolism and cholesterol transport, has been found to be up-regulated in CNS injury and is associated with Alzheimer's disease in humans. In this study, we show that apo-E is also up-regulated after complete spinal cord transection in the C57BL/6 mouse. In the uninjured cord, the cellular localization of apo-E protein is in astrocytes, in individual neurons throughout the laminae except for the dorsal horn, and in endothelial cells of capillaries in the immediate vicinity of those neurons. After injury, RNA levels are elevated as early as 4 days and reach a maximal level between 1 and 2 weeks. Protein levels follow closely but remain up-regulated beyond 3 weeks. Early on, the protein can be found in neutrophils and macrophages at the injury site and only at later times in astrocytes during the remodeling of white matter tracts, most prominently in degenerating parts of the fasciculus gracilis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12526030     DOI: 10.1002/jnr.10482

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

1.  Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway.

Authors:  Caroline S Casey; Yuka Atagi; Yu Yamazaki; Mitsuru Shinohara; Masaya Tachibana; Yuan Fu; Guojun Bu; Takahisa Kanekiyo
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

2.  From Immunity and Vaccines to Mammalian Regeneration.

Authors:  Ellen Heber-Katz
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

3.  AP-2β regulates amyloid beta-protein stimulation of apolipoprotein E transcription in astrocytes.

Authors:  Ximena S Rossello; Urule Igbavboa; Gary A Weisman; Grace Y Sun; W Gibson Wood
Journal:  Brain Res       Date:  2012-01-18       Impact factor: 3.252

4.  Apolipoprotein E epsilon4 allele and outcomes of traumatic spinal cord injury.

Authors:  Amitabh Jha; Daniel P Lammertse; Joseph R Coll; Susan Charlifue; Christopher T Coughlin; Gale G Whiteneck; Gordon Worley
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

5.  Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.

Authors:  Xiaoxin Cheng; Yiyan Zheng; Ping Bu; Xiangbei Qi; Chunling Fan; Fengqiao Li; Dong H Kim; Qilin Cao
Journal:  Exp Neurol       Date:  2017-10-19       Impact factor: 5.330

6.  Apolipoprotein E Deficiency Exacerbates Spinal Cord Injury in Mice: Inflammatory Response and Oxidative Stress Mediated by NF-κB Signaling Pathway.

Authors:  Xuan Yang; Shurui Chen; Zhenya Shao; Yuanlong Li; He Wu; Xian Li; Liang Mao; Zipeng Zhou; Liangjie Bai; Xifan Mei; Chang Liu
Journal:  Front Cell Neurosci       Date:  2018-05-23       Impact factor: 5.505

7.  ABCA1/ApoE/HDL Signaling Pathway Facilitates Myelination and Oligodendrogenesis after Stroke.

Authors:  Li Li; Rongwen Li; Alex Zacharek; Fengjie Wang; Julie Landschoot-Ward; Michael Chopp; Jieli Chen; Xu Cui
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

8.  Electroacupuncture promotes the recovery of rats with spinal cord injury by suppressing the Notch signaling pathway via the H19/EZH2 axis.

Authors:  Xin Geng; Yanghong Zou; Shipeng Li; Renli Qi; Cong Jing; Xiangqian Ding; Jinghui Li; Hualin Yu
Journal:  Ann Transl Med       Date:  2021-05

9.  Gene expression profiling of two distinct neuronal populations in the rodent spinal cord.

Authors:  Jesper Ryge; Ann-Charlotte Westerdahl; Preben Alstrøm; Ole Kiehn
Journal:  PLoS One       Date:  2008-10-15       Impact factor: 3.240

10.  Administration of Downstream ApoE Attenuates the Adverse Effect of Brain ABCA1 Deficiency on Stroke.

Authors:  Xiaohui Wang; Rongwen Li; Alex Zacharek; Julie Landschoot-Ward; Fengjie Wang; Kuan-Han Hank Wu; Michael Chopp; Jieli Chen; Xu Cui
Journal:  Int J Mol Sci       Date:  2018-10-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.